Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06131476 · ClinicalTrials.gov registry record · Phase 1
Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of a Lipid- Based Lubricating Eye Drop
A Phase 1 study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT06131476 is a Phase 1 study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 32 participants.
The verdict
NCT06131476, a Phase 1 study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
This is a single visit, randomized, double masked, bilateral, non-dispensing, 2×2 crossover study to assess visual acuity.
Interventions
- DRUG Blink® Tears eye drops
- DRUG Investigational lipid eye drops
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2020-09-16 |
| Est. Completion | 2020-10-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06131476
The ClinicalTrials.gov registry entry for NCT06131476 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blink® Tears eye drops is the first listed.
NCT06131476 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06131476 about?
NCT06131476 is a clinical study titled "Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of a Lipid- Based Lubricating Eye Drop". This is a single visit, randomized, double masked, bilateral, non-dispensing, 2×2 crossover study to assess visual acuity.
What is the current status of trial NCT06131476?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2020-09-16. Estimated completion is 2020-10-10.
What interventions are being tested in trial NCT06131476?
The interventions under investigation include: Blink® Tears eye drops (DRUG), Investigational lipid eye drops (DRUG).
Who is sponsoring clinical trial NCT06131476?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.